학술논문
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials
Document Type
Article
Author
Source
In: Nature Communications . (Nature Communications, December 2023, 14(1))
Subject
Language
English
ISSN
20411723